Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01306422 · ClinicalTrials.gov registry record · NA

Safety, Tolerability, Kinetics and Efficacy Study of Hoodia Gordonii Purified Extract (PYM50717)

A NA study of Overweight and Body Weight, sponsored by Unilever R&D.

Completed
Registry status
NA
Development phase
64
Enrollment target
1
Study location

NCT01306422 is a NA study of Overweight and Body Weight that has completed, run by Unilever R&D. The registered enrollment target is 64 participants, below the 1,323-participant average among 197 other Overweight trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01306422, a NA study of Overweight and Body Weight, has completed, sponsored by Unilever R&D.

COMPLETED
Registry status
NA
Development phase
64 participants
Enrollment target
1
Study location

Study Summary

The objective of this clinical study was to assess the safety, tolerability, efficacy (effects on appetite scores, food intake) and plasma kinetics of Hoodia gordonii purified extract (H.g.PE), when consumed twice-daily for 2 or 15-days.

Interventions

  • OTHER Hoodia gordonii purified extract (H.g.PE)
  • OTHER Placebo yogurt drink

Study Locations (1)

Wisconsin

  • Covance CRU - Madison

Trial Details

FieldValue
Enrollment Target 64 participants
Start Date 2008-03
Est. Completion 2008-10
Phase NA

Sponsor

Unilever R&D

3 total trials

What the Registry Record Tells You About NCT01306422

The ClinicalTrials.gov registry entry for NCT01306422 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,323-participant average among 197 other Overweight trials with a reported enrollment target (95% lower). The listed sponsor is Unilever R&D, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Overweight appearing as the primary indexed condition, and to 2 interventions - of which Hoodia gordonii purified extract (H.g.PE) is the first listed.

NCT01306422 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT01306422 about?

NCT01306422 is a clinical study titled "Safety, Tolerability, Kinetics and Efficacy Study of Hoodia Gordonii Purified Extract (PYM50717)". The objective of this clinical study was to assess the safety, tolerability, efficacy (effects on appetite scores, food intake) and plasma kinetics of Hoodia gordonii purified extract (H.g.PE), when consumed twice-daily for 2 or 15-days.

What is the current status of trial NCT01306422?

This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2008-03. Estimated completion is 2008-10.

What conditions does trial NCT01306422 study?

This clinical trial studies the following conditions: Overweight, Body Weight, Appetite Depressant.

What interventions are being tested in trial NCT01306422?

The interventions under investigation include: Hoodia gordonii purified extract (H.g.PE) (OTHER), Placebo yogurt drink (OTHER).

Who is sponsoring clinical trial NCT01306422?

This trial is sponsored by Unilever R&D, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01306422 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Overweight

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.